Knight Therapeutics Raises FY2026 Sales Guidance from C$510.000M-C$525.000M to C$540.000M-C$560.000M vs C$519.863M Est
Knight Therapeutics (TSX:GUD) raises FY2026 sales outlook from C$510.000 million-C$525.000 million to C$540.000 million-C$560.000 million vs C$519.863 million estimate.
Knight Therapeutics thinks it will make more money next year than it said before—about C$40 million extra. When a company raises its money prediction, it usually means their business is doing better than expected, which is something to watch.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.